{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:10:05Z","timestamp":1789740605515,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic syndrome is a modifiable risk factor in endometrial cancer patients and is predictive of disease outcomes in endometrial cancer survivors. While metabolic syndrome has been on the rise in the United States, there is also a concerning, disproportionate increase in the prevalence of aggressive endometrial cancer subtypes in Black women and with worse clinical outcomes. The purpose of this narrative review is to summarize the evolving landscape of research and the complex intersectionality of diagnostic and therapeutic disparities and survivorship considerations, in Black women with endometrial cancer. The goal of this review is to bring attention to these disparities to improve gynecologic oncologic care for Black women. Reviewing the mechanisms, molecular and social determinants of disease in this population can provide a foundation for future improvements in research, interventions in prevention, detection, and treatment aiming at improving survival outcomes for Black women with endometrial cancer.<\/jats:p>","DOI":"10.1007\/s40615-026-03177-7","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:53:42Z","timestamp":1789739622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the Associations of Altered Metabolism in Black Women with Endometrial Cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-7802","authenticated-orcid":false,"given":"Ida","family":"Micaily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman G.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"3177_CR1","unstructured":"Surveillance E, Results E. (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Cancer Stat Facts: Uterine Cancer, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024. Underlying mortality data provided by NCHS (www.cdc.gov\/nchs)."},{"key":"3177_CR2","unstructured":"American Cancer Society (ACS). Key Statistics for Endometrial Cancer, released February 28. 2025. Underlying mortality data provided by ACS (https:\/\/www.cancer.org\/cancer\/types\/endometrial-cancer\/about\/key-statistics.html)"},{"key":"3177_CR3","doi-asserted-by":"publisher","first-page":"e080978","DOI":"10.1136\/bmj-2024-080978","volume":"388","author":"BR Corr","year":"2025","unstructured":"Corr BR, Erickson BR, Barber EL, Fisher CM, Slomovitz B. Advances in the management of endometrial cancer. BMJ. 2025;388:e080978. https:\/\/doi.org\/10.1136\/bmj-2024-080978","journal-title":"BMJ"},{"issue":"21","key":"3177_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"kH Lu","year":"2020","unstructured":"Lu kH, Broaddus RR. Endometrial Cancer. N Engl J Med. 2020;383(21):2053\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"3177_CR5","doi-asserted-by":"publisher","first-page":"e238437","DOI":"10.1001\/jamanetworkopen.2023.8437","volume":"6","author":"CW Kucera","year":"2023","unstructured":"Kucera CW, Tian C, Tarney CM, et al. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023;6(4):e238437. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8437.","journal-title":"JAMA Netw Open"},{"key":"3177_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2026.04.004","volume":"209","author":"R Urban","year":"2026","unstructured":"Urban R, Castellano T, Doll K, DeLair D, Wright J, Eskander R, Westin S, Powell M, Craig A, Growdon W, Musa F, Huang M. Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I. Gynecol Oncol. 2026;209:15\u201325.","journal-title":"Gynecol Oncol"},{"issue":"22","key":"3177_CR7","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.19.00151","volume":"37","author":"MA Clarke","year":"2019","unstructured":"Clarke MA, Devesa SS, Harvey SV, Wentzensen N. Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers. J Clin Oncol. 2019;37(22):1895\u2013908.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3177_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajog.2017.09.016","volume":"218","author":"KM Doll","year":"2018","unstructured":"Doll KM, Snyder CR, Ford CL. Endometrial cancer disparities: a race-conscious critique of the literature. Am J Obstet Gynecol. 2018;218(5):474\u2013e4822. https:\/\/doi.org\/10.1016\/j.ajog.2017.09.016.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"3177_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1158\/2159-8290.CD-23-0546","volume":"13","author":"B Weigelt","year":"2023","unstructured":"Weigelt B, Marra A, Selenica P, et al. Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications. Cancer Discov. 2023;13(11):2356\u201369. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0546.","journal-title":"Cancer Discov"},{"key":"3177_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ygyno.2024.03.026","volume":"183","author":"ZA Kopelman","year":"2024","unstructured":"Kopelman ZA, Tian C, Tumas J, et al Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG\/NRG oncology randomized phase III clinical trials. Gynecol Oncol. 2024;183:103\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.026.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3177_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/diagnostics14040417","volume":"14","author":"O Illah","year":"2024","unstructured":"Illah O, Adeeko D, Olaitan A, Gentry-Maharaj A. Racioethnic Disparities in Endometrial Cancer Outcomes. Diagnostics (Basel). 2024;14(4):417. https:\/\/doi.org\/10.3390\/diagnostics14040417.","journal-title":"Diagnostics (Basel)"},{"key":"3177_CR12","doi-asserted-by":"publisher","unstructured":"Leonis R, Chavez T, Caldwell A, et al. Inequities in surgical access for women with endometrial cancer in the United States: opportunities for surgical justice. Am Surg. 2025; 91(5):746\u201350. https:\/\/doi.org\/10.1177\/00031348251318376","DOI":"10.1177\/00031348251318376"},{"issue":"1","key":"3177_CR13","doi-asserted-by":"publisher","first-page":"bgaf004","DOI":"10.1093\/carcin\/bgaf004","volume":"46","author":"E Hoos","year":"2025","unstructured":"Hoos E, Koval LE, Corcoran DL. Epigenetic mechanisms underlying endometrial cancer outcomes: race-specific patterns of DNA methylation associated with molecular subtypes and survival. Carcinogenesis. 2025;46(1):bgaf004. . https:\/\/doi.org\/10.1093\/carcin\/bgaf004","journal-title":"Carcinogenesis"},{"issue":"1","key":"3177_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ygyno.2022.04.014","volume":"166","author":"AE Wilhite","year":"2022","unstructured":"Wilhite AE, Baca Y, Xiu J, et al. Molecular profiles of endometrial cancer tumors among Black patients. Gynecol Oncol. 2022;166(1):108\u201316. https:\/\/doi.org\/10.1016\/j.ygyno.2022.04.014.","journal-title":"Gynecol Oncol"},{"key":"3177_CR15","doi-asserted-by":"publisher","first-page":"1445128","DOI":"10.3389\/fonc.2024.1445128","volume":"14","author":"H Karpel","year":"2024","unstructured":"Karpel H, Friedman S, Hacker KE, Pothuri B eCollection. Race- associated molecular differences in uterine serous carcinoma. Front Oncol. 2024;14:1445128. https:\/\/doi.org\/10.3389\/fonc.2024.1445128.","journal-title":"Front Oncol"},{"issue":"1","key":"3177_CR16","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1038\/s41467-024-52554-5","volume":"15","author":"LM Brown","year":"2024","unstructured":"Brown LM, Hagenson RA, Koklic T, et al. An elevated rate of whole-genome duplications in cancers from Black patients. Nat Commun. 2024;15(1):8218. https:\/\/doi.org\/10.1038\/s41467-024-52554-5.","journal-title":"Nat Commun"},{"issue":"5","key":"3177_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10552-022-01653-z","volume":"34","author":"TR Sponholtz","year":"2023","unstructured":"Sponholtz TR, Palmer JR, Rosenberg L, Chen C, Chen Y, Clarke MA, et al. Risk factors for endometrial cancer in Black women. Cancer Causes Control. 2023;34(5):421\u201330.","journal-title":"Cancer Causes Control"},{"key":"3177_CR18","doi-asserted-by":"crossref","unstructured":"Miller AK, Gordon JC, Curtis JW, Ajayakumar J, Schumacher FR, Avril S. The geographic context of racial disparities in aggressive endometrial cancer subtypes: integrating social and environmental aspects to discern biological outcomes. Int J Environ Res Public Health. 2022;19(14):8613.","DOI":"10.3390\/ijerph19148613"},{"issue":"Pt 1","key":"3177_CR19","doi-asserted-by":"publisher","first-page":"117228","DOI":"10.1016\/j.envres.2023.117228","volume":"239","author":"KA Bertrand","year":"2023","unstructured":"Bertrand KA, Delp L, Coogan PF, Cozier YC, Lenzy YM, Rosenberg L, et al. Hair relaxer use and risk of uterine cancer in the Black Women\u2019s Health Study. Environ Res. 2023;239(Pt 1):117228.","journal-title":"Environ Res"},{"issue":"5","key":"3177_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12170-013-0328-7","volume":"7","author":"P Agyemang","year":"2013","unstructured":"Agyemang P, Powell-Wiley TM. Obesity and Black Women: Special Considerations Related to Genesis and Therapeutic Approaches. Curr Cardiovasc Risk Rep. 2013;7(5):378\u201386.","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"8","key":"3177_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomid D, et al. Body Fatness and cancer\u2014Viewpoint of the IARC Working Group. NEJM. 2016;375(8):794\u20138.","journal-title":"NEJM"},{"issue":"1","key":"3177_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/jcrt.jcrt_480_24","volume":"21","author":"AS Jayraj","year":"2025","unstructured":"Jayraj AS, Kumar S, Sharma DN, Khadgawat R, Kumar L, Perumal V, Meena J, Singhal S. The serum levels of leptin and adiponectin in endometrial carcinoma and their association with histopathological factors. Journal of Cancer Research and Therapeutics. 2025;21(1):98\u2013103. https:\/\/doi.org\/10.4103\/jcrt.jcrt_480_24.","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"3177_CR23","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.gore.2024.101430","volume":"54","author":"NL Santiago","year":"2024","unstructured":"Santiago NL, Ituarte PH, Kohut A, et al. The effect of food deserts on gynecologic cancer survival. Gynecol Oncol Rep. 2024;54:101430. https:\/\/doi.org\/10.1016\/j.gore.2024.101430. eCollection 2024 Aug.","journal-title":"Gynecol Oncol Rep"},{"key":"3177_CR24","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-11-0545","volume":"10","author":"HS Moon","year":"2011","unstructured":"Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S, Mantzoros CS. Direct role of adiponectin and adiponectin receptors in endometrial cancer: In vitro and ex vivo studies in humans. Mol Cancer Ther. 2011;10:2234\u201343. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0545.","journal-title":"Mol Cancer Ther"},{"key":"3177_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/path.5874","volume":"257","author":"Y Yan","year":"2022","unstructured":"Yan Y, Shi H, Zhao Z, Wang S, Zhou S, Mu Y, et al. Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen-activated protein kinase. J Pathol. 2022;257:146\u201357. https:\/\/doi.org\/10.1002\/path.5874.","journal-title":"J Pathol"},{"key":"3177_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1677\/ERC-07-0065","volume":"14","author":"L Cong","year":"2007","unstructured":"Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2. Endocr Relat Cancer. 2007;14:713\u201320. https:\/\/doi.org\/10.1677\/ERC-07-0065.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3177_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2003.07.002","volume":"53","author":"MW Hulver","year":"2004","unstructured":"Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004;53(1):1\u20133.","journal-title":"Metabolism"},{"issue":"3","key":"3177_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cancers16030531","volume":"16","author":"I Ray","year":"2024","unstructured":"Ray I, M\u00f6ller-Levet CS, Michael A, Butler-Manuel S, Chatterjee J, Tailor A, Ellis PE, Meira LB. Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer. Cancers. 2024;16(3):531. https:\/\/doi.org\/10.3390\/cancers16030531.","journal-title":"Cancers"},{"issue":"5","key":"3177_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12170-013-0328-7","volume":"7","author":"P Agyemang","year":"2013","unstructured":"Agyemang P, Powell-Wiley TM. Obesity and black women: special considerations related to genesis and therapeutic approaches. Curr Cardiovasc Risk Rep. 2013;7(5):378\u201386.","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"3177_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","volume":"417","author":"A Yadav","year":"2013","unstructured":"Yadav A, Kataria MA, Saini V, et al. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80\u20134. https:\/\/doi.org\/10.1016\/j.cca.2012.12.007.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"3177_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","volume":"61","author":"UI Khan","year":"2012","unstructured":"Khan UI, Wang D, Sowers MR, et al. Race-ethnic differences in adipokine levels: The Study of Women\u2019s Health Across the Nation (SWAN). Metabolism. 2012;61(9):1261\u20139. https:\/\/doi.org\/10.1016\/j.metabol.2012.02.005.","journal-title":"Metabolism"},{"issue":"10","key":"3177_CR32","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/oby.2010.346","volume":"19","author":"SS Cohen","year":"2011","unstructured":"Cohen SS, Gammon MD, North KE, et al. ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women. Obesity. 2011;19(10):2053\u201362. https:\/\/doi.org\/10.1038\/oby.2010.346.","journal-title":"Obesity"},{"key":"3177_CR33","doi-asserted-by":"crossref","unstructured":"Turbitt WJ, Demark-Wahnefried W, Peterson CM, Norian LA. Targeting glucose metabolism to enhance immunotherapy: Emerging evidence on intermittent fasting and calorie restriction mimetics. Front Immunol, 2019;10:1402.","DOI":"10.3389\/fimmu.2019.01402"},{"issue":"9","key":"3177_CR34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","volume":"16","author":"Collaborative Group on Epidemiological Studies on Endometrial Cancer","year":"2015","unstructured":"Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27,276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16(9):1061\u201370.","journal-title":"Lancet Oncol"},{"key":"3177_CR35","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.1038\/srep14243","volume":"5","author":"QJ Wu","year":"2015","unstructured":"Wu QJ, Li YY, Tu C, et al. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep. 2015;5:14243.","journal-title":"Sci Rep"},{"issue":"6","key":"3177_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/AOG.0000000000002057","volume":"129","author":"SJ Jordan","year":"2017","unstructured":"Jordan SJ, Na R, Johnatty SE, et al. Breastfeeding and endometrial cancer risk: an analysis from the Epidemiology of Endometrial Cancer Consortium. Obstet Gynecol. 2017;129(6):1059\u201367.","journal-title":"Obstet Gynecol"},{"key":"3177_CR37","unstructured":"PDQ Adult Treatment Editorial Board. Endometrial Cancer Prevention (PDQ\u00ae): Health Professional Version. Bethesda, MD: National Cancer Institute; 2025 May 6. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002 Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65758\/"},{"issue":"6","key":"3177_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.annepidem.2007.11.011","volume":"18","author":"RM Beining","year":"2008","unstructured":"Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol. 2008;18(6):492\u20139.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"3177_CR39","doi-asserted-by":"publisher","first-page":"e1911","DOI":"10.1016\/j.ajog.2020.08.032","volume":"224","author":"SN Westin","year":"2021","unstructured":"Westin SN, Fellman B, Sun CC, et al. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol. 2021;224(2):e1911\u201319115.","journal-title":"Am J Obstet Gynecol"},{"key":"3177_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ygyno.2026.05.006","volume":"209","author":"R Urban","year":"2026","unstructured":"Urban R, Eskander R, Westin S, Powell M, Craig A, Growdon W, Musa F, Huang M. Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part II. Gynecol Oncol. 2026;209:120\u201330.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3177_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ajog.2024.07.018","volume":"231","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, Ferris JS, Chen L, Dioun S, Usseglio J, Matsuo K, et al. Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024;231(6):599\u2013e61017.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3177_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ygyno.2021.01.029","volume":"161","author":"M Janda","year":"2021","unstructured":"Janda M, Robledo KP, Gebski V, Armes JE, Alizart M, Cummings M, et al. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial. Gynecol Oncol. 2021;161(1):143\u201351.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3177_CR43","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0896920510380948","volume":"37","author":"TW Volscho","year":"2011","unstructured":"Volscho TW. Racism and disparities in women\u2019s use of the Depo-Provera injection in the contemporary USA. Crit Sociol. 2011;37(5):673\u201388.","journal-title":"Crit Sociol"},{"issue":"7","key":"3177_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1089\/jwh.2015.5637","volume":"25","author":"C Prather","year":"2016","unstructured":"Prather C, Fuller TR, Marshall KJ, Jeffries WL. The impact of racism on the sexual and reproductive health of African American women. J Womens Health (Larchmt). 2016;25(7):664\u201371.","journal-title":"J Womens Health (Larchmt)"},{"key":"3177_CR45","volume-title":"Killing the Black Body: Race, Reproduction, and the Meaning of Liberty","author":"D Roberts","year":"1997","unstructured":"Roberts D. Killing the Black Body: Race, Reproduction, and the Meaning of Liberty. New York, NY: Pantheon Books; 1997."},{"issue":"5","key":"3177_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.contraception.2018.01.006","volume":"97","author":"RD Kramer","year":"2018","unstructured":"Kramer RD, Higgins JA, Godecker AL. Racial and ethnic differences in patterns of long-acting reversible contraceptive use in the United States, 2011\u20132015. Contraception. 2018;97(5):399\u2013404.","journal-title":"Contraception"},{"key":"3177_CR47","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.conx.2020.100032","volume":"2","author":"KL Burke","year":"2020","unstructured":"Burke KL, Potter JE, White K. Unsatisfied contraceptive preferences due to cost among women in the United States. Contracept X. 2020;2:100032.","journal-title":"Contracept X"},{"issue":"11","key":"3177_CR48","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.2105\/AJPH.2016.303393","volume":"106","author":"JA Higgins","year":"2016","unstructured":"Higgins JA, Kramer RD, Ryder KM. Provider bias in long-acting reversible contraception (LARC) promotion and removal: perceptions of young adult women. Am J Public Health. 2016;106(11):1932\u20137.","journal-title":"Am J Public Health"},{"issue":"8","key":"3177_CR49","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/jamaoncol.2024.1891","volume":"10","author":"KM Doll","year":"2024","unstructured":"Doll KM, Pike M, Alson J, et al. Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. JAMA Oncol. 2024;10(8):1068\u201376. https:\/\/doi.org\/10.1001\/jamaoncol.2024.1891.","journal-title":"JAMA Oncol"},{"issue":"25","key":"3177_CR50","doi-asserted-by":"publisher","first-page":"00157","DOI":"10.1016\/j.ajog.2025.03.012","volume":"S00029378","author":"JG Alson","year":"2025","unstructured":"Alson JG, Orellana M, Robinson WR, et al Facilitators and barriers to acceptability of a biopsy-first approach in the diagnostic evaluation for endometrial cancer among Black women. Am J Obstet Gynecol. 2025;S0002-9378(25):00157\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2025.03.012.","journal-title":"Am J Obstet Gynecol"},{"key":"3177_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2025.02.006","volume":"194","author":"C Nolin","year":"2025","unstructured":"Nolin C, Atkins SL, Myers ER, et al. Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals. Gynecol Oncol. 2025;194:105\u201311. https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.006.","journal-title":"Gynecol Oncol"},{"issue":"25","key":"3177_CR52","first-page":"00157","volume":"S0002-9378","author":"JG Alson","year":"2025","unstructured":"Alson JG, Orellana M, Robinson WR, et al. Facilitators and barriers to acceptability of a biopsy-first approach in the diagnostic evaluation for endometrial cancer among Black women. Am J Obstet Gynecol. 2025;S0002-9378(25):00157\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3177_CR53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.18865\/ed.30.4.543","volume":"30","author":"SS Romano","year":"2020","unstructured":"Romano SS, Doll KM. The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women. Ethn Dis. 2020;30(4):543\u201352. https:\/\/doi.org\/10.18865\/ed.30.4.543.","journal-title":"Ethn Dis"},{"issue":"2","key":"3177_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajog.2022.03.004","volume":"227","author":"DA Barrington","year":"2022","unstructured":"Barrington DA, Sinnott JA, Nixon D, et al. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer. Am J Obstet Gynecol. 2022;227(2):244. e1-244.e17.","journal-title":"Am J Obstet Gynecol"},{"issue":"25","key":"3177_CR55","doi-asserted-by":"publisher","first-page":"00048","DOI":"10.1016\/j.ajog.2025.01","volume":"S0002-9378","author":"G Levin","year":"2025","unstructured":"Levin G, Monk BJ, Pothuri B, et al. Racial and ethnic enrollment disparities in clinical trials leading to Food and Drug Administration approvals for gynecologic malignancies. Am J Obstet Gynecol. 2025;S0002-9378(25):00048\u20131. https:\/\/doi.org\/10.1016\/j.ajog.2025.01.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3177_CR56","doi-asserted-by":"publisher","first-page":"e22928","DOI":"10.1002\/cncy.22928","volume":"133","author":"B Nelson","year":"2025","unstructured":"Nelson B, Faquin W. Counseling gap may worsen endometrial cancer disparities in Black women: A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counseling. Cancer Cytopathol. 2025;133(1):e22928. https:\/\/doi.org\/10.1002\/cncy.22928.","journal-title":"Cancer Cytopathol"},{"key":"3177_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.seminoncol.2013.09.011","volume":"40","author":"ES Tonorezos","year":"2013","unstructured":"Tonorezos ES, Jones LW. Energy balance and metabolism after cancer treatment. Semin Oncol. 2013;40:745\u201356.","journal-title":"Semin Oncol"},{"issue":"3","key":"3177_CR58","first-page":"125","volume":"10","author":"T Van Soom","year":"2018","unstructured":"Van Soom T, Tjalma W, El Bakkali S, et al. Perspective: Towards Personalised Metabolic Coaching in Cancer. Facts Views Vis Obgyn. 2018;10(3):125\u201330.","journal-title":"Facts Views Vis Obgyn"},{"key":"3177_CR59","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.e13870","author":"S Nair","year":"2025","unstructured":"Nair S, Srinivasan T, Geroni D, et al. Patient preferences for survivorship educational programs. J Clin Oncol. 2025;43:16_suppl. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.e13870.","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"3177_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/obr.12212","volume":"15","author":"BC Wingo","year":"2014","unstructured":"Wingo BC, Carson TL, Ard J. Differences in weight loss and health outcomes among African Americans and Whites in multicentre trials. Obes Rev. 2014;15(Suppl 4):46\u201361.","journal-title":"Obes Rev"},{"issue":"12","key":"3177_CR61","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1123\/jpah.2014-0243","volume":"12","author":"KK Davis","year":"2015","unstructured":"Davis KK, Tate DF, Lang W, et al. Racial differences in weight loss among adults in a behavioral weight loss intervention: Role of diet and physical activity. J Phys Act Health. 2015;12(12):1558\u201366.","journal-title":"J Phys Act Health"},{"issue":"4","key":"3177_CR62","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/ijerph7041720","volume":"7","author":"SN Sweet","year":"2010","unstructured":"Sweet SN, Fortier MS. Improving physical activity and dietary behaviours with single or multiple health behaviour interventions? A synthesis of meta-analyses and reviews. Int J Environ Res Public Health. 2010;7(4):1720\u201343.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"3177_CR63","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jand.2012.02.003","volume":"26","author":"DCS James","year":"2012","unstructured":"James DCS, Pobee JW, Oxidine D, et al. Using the Health Belief Model to Develop Culturally Appropriate Weight-Management Materials for African-American Women. J Acad Nutr Diet. 2012;26(8):664\u201370.","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"3177_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1467-789X.2011.00945.x","volume":"13","author":"ML Fitzgibbon","year":"2012","unstructured":"Fitzgibbon ML, Tussing-Humphreys LM, Porter JS, Martin IK, Odoms-Young A, Sharp LK. Weight loss and African-American women: A systematic review of the behavioural weight loss intervention literature. Obes Rev. 2012;13(3):193\u2013213.","journal-title":"Obes Rev"},{"key":"3177_CR65","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.clnu.2017.01.007","volume":"37","author":"A Juinot","year":"2018","unstructured":"Juinot A, Vazeille C, Durand JP, et al. Resting energy expenditure in the risk assessment of anticancer treatments. Clin Nutr. 2018;37:558\u201365.","journal-title":"Clin Nutr"},{"issue":"1","key":"3177_CR66","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/ajcn\/76.1.187","volume":"76","author":"S Nesby-O\u2019Dell","year":"2002","unstructured":"Nesby-O\u2019Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination. Am J Clin Nutr. 2002;76(1):1988\u201394.","journal-title":"Am J Clin Nutr"},{"key":"3177_CR67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.e13872","author":"S Nair","year":"2025","unstructured":"Nair S, Srinivasan T, Geroni D, et al. Identifying barriers to implementing survivorship support programs for oncology patients. J Clin Oncol. 2025;43:16_suppl. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.e13872.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3177_CR68","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cncr.31985","volume":"125","author":"TG Ketterl","year":"2019","unstructured":"Ketterl TG, Syrjala KL, Casillas J, et al. Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors. Cancer. 2019;125(11):1908\u201317.","journal-title":"Cancer"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-026-03177-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-026-03177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:53:45Z","timestamp":1789739625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-026-03177-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":68,"alternative-id":["3177"],"URL":"https:\/\/doi.org\/10.1007\/s40615-026-03177-7","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is an observational study. The Thomas Jefferson University IRB and Research Ethics Committee have confirmed that no ethical approval is required.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}